- Home
- CYRX vs PGEN Comparison
CYRX vs PGEN Comparison
Compare CYRX & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | PGEN |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.7M | 1.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CYRX | PGEN |
|---|---|---|
| Price | $9.56 | $4.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $12.83 | $7.67 |
| AVG Volume (30 Days) | 457.4K | ★ 5.1M |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $243,795,000.00 | $6,309,000.00 |
| Revenue This Year | N/A | $342.78 |
| Revenue Next Year | $9.26 | $478.46 |
| P/E Ratio | $7.57 | ★ N/A |
| Revenue Growth | 41.27 | ★ 59.20 |
| 52 Week Low | $4.58 | $1.03 |
| 52 Week High | $11.44 | $5.23 |
Technical Indicators
Market Signals| Indicator | CYRX | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 52.10 | 55.61 |
| Support Level | $9.40 | $4.05 |
| Resistance Level | $9.87 | $4.53 |
| Average True Range (ATR) | 0.33 | 0.29 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 57.47 | 72.17 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.